BPC-157 dosage: what the research actually used in 2026

Most BPC-157 research used small doses, not big ones. BPC-157 is a synthetic peptide based on a sequence found in gastric juice, and it is thought to act on the VEGFR2 pathway to support angiogenesis, the growth of new blood vessels that carry nutrients into healing tissue.

In animal studies the common dose was about 10 micrograms per kilogram of body weight. In educational human protocols, people describe 250 to 500 micrograms once or twice a day by injection, run in short 4 to 8 week cycles. Because no human trial has set an official dose, a prescribing physician sets the amount that fits you.

What is a typical BPC-157 dosage?

There's no official BPC-157 dosage. Most of what people cite comes from animal studies and educational protocols, not approved human trials. In research, the common animal dose was about 10 micrograms per kilogram of body weight. In educational human protocols, the amounts most often described are 250 to 500 micrograms, taken once or twice a day.

• Animal study standard: about 10 mcg per kg of body weight
• Educational human range: 250 to 500 mcg, once or twice daily
• Broader research range: roughly 200 to 800 mcg per day
• Cycle length: often 4 to 8 weeks for acute strains

What dose ranges show up in BPC-157 research?

BPC-157 doses cluster in a fairly narrow band. Animal studies leaned on roughly 10 mcg per kg. Educational human protocols tend to describe 250 to 500 mcg per dose. The wider research conversation spans about 200 to 800 mcg per day. Higher isn't treated as better; most protocols stay low and consistent.

One note on the animal-to-human math: a 10 mcg per kg rat dose converts to only about 1.6 mcg per kg in a person using body-surface-area scaling. Human protocols usually run higher than that pure conversion, which is why a physician sets the working dose rather than a fixed chart.

How does BPC-157 dosing scale with body weight?

Some protocols set BPC-157 by body weight, others use a flat dose. Weight-based versions describe roughly 2 to 7 mcg per kg per day, split into one or two doses. A flat dose ignores weight and simply uses 250 to 500 mcg per dose. Both approaches show up in educational material.

• Weight-based: about 2 to 7 mcg per kg per day, once or twice
• Flat dose: 250 to 500 mcg per dose, regardless of weight
• Example, weight-based: an 80 kg adult at 3 mcg per kg is ~240 mcg per day
• Example, flat: 250 mcg twice daily is 500 mcg per day

The gap between these methods is small at typical body weights, which is why most protocols land near a few hundred micrograms a day either way.

Does the dose change for injection versus oral?

The route can shift how much is used. BPC-157 is stable in gastric juice, which is why oral capsules exist, and some people use them for gut-focused goals. Injections are dosed near the numbers above. Oral protocols often use similar or slightly higher amounts because absorption differs.

• Subcutaneous injection: 250 to 500 mcg per dose is the common educational range
• Oral capsule: similar per-dose amounts, sometimes higher, often aimed at gut goals
• Local injection near a strain is a common approach in recovery protocols
• The peptide's gastric-juice stability is why an oral form is even possible

For a full route comparison, see BPC-157 oral vs injection.

How long is a BPC-157 cycle, and when is it taken?

BPC-157 is usually described as a short course, not a forever supplement. Educational protocols run about 4 to 8 weeks for a fresh strain and 8 to 12 weeks for longer-standing issues, then a break. Dosing is often split morning and evening, and some people time a dose near the area they're working to recover.

• Acute strain: about 4 to 8 weeks
• Longer-standing issues: about 8 to 12 weeks, then a pause
• Frequency: once or twice daily is the common pattern
• Timing: often morning and evening; some dose near the recovery area

For how BPC-157 fits alongside other recovery peptides, see best peptides for injury recovery.

How is a BPC-157 dose measured from a vial?

BPC-157 comes as a powder that has to be mixed with bacteriostatic water before any dose is drawn. The water you add sets the concentration, and the concentration decides how many units on an insulin syringe equal your dose. This is where mistakes happen with self-mixed research vials, because there's no pharmacist checking the math.

What does the evidence say about BPC-157 doses?

BPC-157 has been studied mainly in animal models, where it is thought to act on the VEGFR2 and nitric oxide pathways to promote angiogenesis, the growth of new blood vessels that carry nutrients into healing tissue. Those studies used the doses above and showed a wide safety margin. Human protocols draw on the same amounts, and reported effects in educational use tend to be mild. Because a formal human dose has not been set, a physician sets the amount that fits you.

• Most published research is animal work studying how BPC-157 supports tissue repair and new blood vessel growth
• The common animal dose showed no major adverse effects in those studies
• Educational human reports describe mild, short-lived effects at typical doses
• A physician confirms fit and sets the dose, which is how BPC-157 should be used

For what to watch for, see BPC-157 side effects.

Why the biggest dosing risk is the source, not the number

The real danger with BPC-157 dosing right now isn't the microgram target. It's that today's easy-to-find vials are research-grade or grey-market, sold with no prescriber and no pharmacy behind them. That means no one verifies the potency, the purity, or that the label matches what's inside, so your "250 mcg" may not be 250 mcg at all.

• Research-grade vials are labeled "not for human use" and skip pharmacy checks
• Actual potency can differ from the label, which throws off every dose
• No prescriber means no one screening whether it fits you
• A precise dose from an unverified vial is still an unverified dose

For more on this, see where to buy BPC-157.

How pru approaches BPC-157 and dosing

pru is a telehealth platform where a licensed physician confirms fit and an FDA-regulated 503A pharmacy compounds and fills what's prescribed. You pick the peptide with pru's guidance; the physician confirms it makes sense for you. Membership is about $50 a month, and peptides are billed separately at cost, itemized, with no markup. Being proactive about recovery is a smart, responsible move, and pru exists to make that informed choice the accessible one: licensed physicians, pharmacy-grade medicine, and at-cost pricing on one path.

On BPC-157 specifically: the FDA removed it from the 503A Category 2 list in April 2026, and the Pharmacy Compounding Advisory Committee reviews it on July 23 to 24, 2026 to weigh whether it can be compounded through 503A pharmacies. Removal from Category 2 is not FDA approval, and it's not the same as being on the authorized 503A list yet. pru is preparing to offer BPC-157 the right way, physician-prescribed and pharmacy-compounded, pending that July 2026 review.

Related reading

• BPC-157 guide
• BPC-157 side effects
• BPC-157 oral vs injection
• BPC-157 and TB-500 stack
• Best peptides for injury recovery
• Best peptides for tendon repair
• Shop GHK-Cu cream

Common questions